H. Han

Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer.

S. Raab, J. Silverman, C. Sturgis, 2002, Human pathology.

Prognostic significance of HER2/neu, p53, and vascular endothelial growth factor expression in early stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung

J. Silverman, R. Landreneau, H. Han, 2004, Modern Pathology.

Prognostic significance of thyroid transcription factor-1 expression in both early-stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung.

J. Silverman, R. Landreneau, H. Han, 2004, Human pathology.

Vascular Endothelial Growth Factor Expression in Stage I Non-Small Cell Lung Cancer Correlates With Neoangiogenesis and a Poor Prognosis

J. Silverman, R. Weyant, R. Landreneau, 2001, Annals of Surgical Oncology.

MD-ALL: an Integrative Platform for Molecular Diagnosis of B-cell Acute Lymphoblastic Leukemia

H. Han, Jiangyue Liu, Allen Mao, 2023, Research square.

MiR-224 promotes lymphatic metastasis by targeting ANGPTL1 in non-small-cell lung carcinoma.

Yue Yang, H. Han, F. Liang, 2021, Cancer biomarkers : section A of Disease markers.

460MO Preliminary results from a phase I study using the bispecific, human epidermal growth factor 2 (HER2)-targeting antibody-drug conjugate (ADC) zanidatamab zovodotin (ZW49) in solid cancers

A. Tolcher, K. Jhaveri, A. Spira, 2022, Annals of Oncology.